It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...
In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...
Agostini’s Ltd has changed its name to Agostini Ltd. The name change follows a meeting of its shareholders today.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on aTyr Pharma (ATYR – Research Report), Crispr Therapeutics AG ...
COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a ...
COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...
LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company specializing in the development of treatments for ocular conditions and currently valued at $37 million, has ...
As a market leader, Rocket Companies rebranding comes in the foreground of several court battles and fluctuating earnings ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...
Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...